| Not Yet Recruiting | A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients W NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors | Phase 4 | 2026-04-30 |
| Not Yet Recruiting | Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial Non-small Cell Lung Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery Ipsilateral Shoulder Pain, Video-Assisted Thoracoscopic Surgery | N/A | 2026-04-01 |
| Not Yet Recruiting | Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell L NSCLC Stage II | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis, MDR-TB | Phase 2 | 2026-02-21 |
| Not Yet Recruiting | A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a M Lung Cancer | — | 2026-02-05 |
| Not Yet Recruiting | Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted T Pain Management | Phase 4 | 2026-02-01 |
| Recruiting | Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectab NSCLC Stage II, NSCLC Stage III | Phase 2 | 2026-01-10 |
| Recruiting | IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Sta Unresectable Stage III Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) | Phase 2 | 2026-01-07 |
| Recruiting | Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Ce EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable | Phase 2 | 2026-01-01 |
| Recruiting | Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function Residual Neuromuscular Block | N/A | 2025-12-31 |
| Recruiting | Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Lung Cancer, PET-CT | — | 2025-12-01 |
| Not Yet Recruiting | Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC NSCLC Stage III, Ensartinib, Chemoradiotherapy | Phase 2 | 2025-12-01 |
| Not Yet Recruiting | Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT Lung Adenocarcinoma | Phase 3 | 2025-10-01 |
| Not Yet Recruiting | Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease Fibrotic Interstitial Lung Disease | Phase 4 | 2025-10-01 |
| Not Yet Recruiting | Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung C NSCLC, MET Exon 14 Mutation, MET Activating Mutation | Phase 2 | 2025-09-20 |
| Recruiting | Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine Postoperative Pain, Acute, Lung Cancer | N/A | 2025-09-01 |
| Not Yet Recruiting | Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency Premature Ovarian Insufficiency | N/A | 2025-09-01 |
| Not Yet Recruiting | Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-S Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis | Phase 2 | 2025-08-20 |
| Not Yet Recruiting | Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Postoperative Incidental Small Cell Lung Cancer, Toripalimab Adjuvant Therapy Evaluation | Phase 2 | 2025-08-01 |
| Not Yet Recruiting | A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Lung Cancer | Phase 2 | 2025-08-01 |
| Recruiting | Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II- Lung Cancer (NSCLC) | Phase 2 | 2025-06-19 |
| Withdrawn | Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer Lung Cancer (NSCLC), Neoadjuvant Immunotherapy | — | 2025-04-30 |
| Not Yet Recruiting | Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable No Resectable Non-small Cell Lung Cancer, Bispecific Antibody, Neoadjuvant Therapy | Phase 2 | 2025-04-21 |
| Recruiting | The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping Bronchiectasis Adult | — | 2025-04-06 |
| Not Yet Recruiting | The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Ris NSCLC, ALK, Stage I | Phase 2 | 2025-03-15 |
| Not Yet Recruiting | Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCL Locally Advanced Non-Small Cell Lung Cancer | Phase 2 | 2025-02-18 |
| Recruiting | Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer Extensive-stage Small Cell Lung Cancer (ES-SCLC), Thoracic Neoplasms, Lung Neoplasms | Phase 2 | 2025-02-07 |
| Enrolling By Invitation | The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery Lung Cancer (Diagnosis), Hypoxemia | — | 2024-12-23 |
| Recruiting | An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR Lung Cancer | Phase 2 | 2024-11-19 |
| Not Yet Recruiting | Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) Potentially Resectable MET-altered Non-Small Cell Lung Cancer | Phase 2 | 2024-11-01 |
| Not Yet Recruiting | Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lu Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent | Phase 2 | 2024-11-01 |
| Not Yet Recruiting | The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-pos ALK, NSCLC | — | 2024-10-30 |
| Active Not Recruiting | Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutatio Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | 2024-10-17 |
| Recruiting | Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) Bronchiectasis Adult | — | 2024-10-16 |
| Recruiting | WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma Lung Adenocarcinoma, Whole Slide Image, IASLC Grading System | — | 2024-10-15 |
| Not Yet Recruiting | The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns Lung Cancer | — | 2024-10-01 |
| Not Yet Recruiting | A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCL Lung Cancer (NSCLC) | Phase 2 | 2024-10-01 |
| Not Yet Recruiting | A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung SCLC, Extensive Stage | Phase 2 | 2024-09-30 |
| Not Yet Recruiting | Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Ma Non Small Cell Lung Cancer | Phase 2 | 2024-09-30 |
| Not Yet Recruiting | Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung C Unresectable Stage III Non-small-cell Lung Cancer | — | 2024-09-20 |
| Recruiting | A Study on the Efficacy of Atezolizumab Combined with Chemotherapy Lung Cancer, Small Cell | — | 2024-08-28 |
| Not Yet Recruiting | A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Extensive-stage Small Cell Lung Cancer (ES-SCLC) | — | 2024-08-01 |
| Not Yet Recruiting | SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First- NSCLC | Phase 2 | 2024-07-15 |
| Not Yet Recruiting | The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patient NSCLC | — | 2024-07-08 |
| Recruiting | Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma Non-Small Cell Lung Cancer | Phase 2 | 2024-06-05 |
| Not Yet Recruiting | Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer Lung Cancer Non-small Cell Stage IV | Phase 2 | 2024-06-01 |
| Active Not Recruiting | Toripalimab Combined With SBRT for NSCLC Non-small Lung Cancer | Phase 2 | 2024-04-15 |
| Recruiting | Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-s Limited Stage Small Cell Lung Cancer | Phase 2 | 2024-04-01 |
| Recruiting | Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules Pulmonary Nodule | N/A | 2024-03-14 |
| Not Yet Recruiting | Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Potentially Resectable ALK Positive Non-Small Cell Lung Cancer | Phase 2 | 2024-03-01 |
| Recruiting | Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Adv Lung Cancer | Phase 2 | 2024-02-02 |
| Recruiting | LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer NSCLC, PD-1 | Phase 2 | 2024-01-12 |
| Not Yet Recruiting | Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer Stage II-IIIB(N2) Non-small Cell Lung Cancer | Phase 2 | 2023-12-20 |
| Recruiting | Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study Lung Cancer | — | 2023-12-16 |
| Recruiting | Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer Non-small Cell Lung Cancer | — | 2023-12-01 |
| Recruiting | Robot-assisted vs VATS for Thymoma Thymoma | N/A | 2023-11-20 |
| Unknown | Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment Lung Cancer | — | 2023-11-07 |
| Recruiting | Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell L Non-small Cell Lung Cancer | — | 2023-10-25 |
| Unknown | Neoadjuvant Treatment For Locally Advanced Thymic Cancer Thymic Carcinoma | Phase 2 | 2023-09-04 |
| Recruiting | Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis Bronchiectasis Adult | N/A | 2023-09-01 |
| Unknown | The Efficacy and Safety of KN046 Combined With Axitinib NSCLC | Phase 2 / Phase 3 | 2023-08-25 |
| Not Yet Recruiting | The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induct Limited Stage Small Cell Lung Cancer | Phase 3 | 2023-08-01 |
| Recruiting | Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC NSCLC | Phase 2 | 2023-07-04 |
| Not Yet Recruiting | Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectabl Stage III Non-small Cell Lung Cancer | Phase 2 | 2023-07-01 |
| Not Yet Recruiting | Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer Lung Cancer | — | 2023-06-01 |
| Unknown | Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung Cancer Lung Cancer, Malignant Airway Obstruction | — | 2023-06-01 |
| Unknown | Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer Immunotherapy Lung Cancer | — | 2023-06-01 |
| Recruiting | Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environme Lung Cancer | — | 2023-05-25 |
| Unknown | Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non Non-small Cell Lung Cancer, Neoadjuvant Chemoimmunotherapy, Complete Pathological Response | — | 2023-05-01 |
| Unknown | Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer Non-small Cell Lung Cancer, Spread Through Air Space, Visceral Pleural Invasion | — | 2023-05-01 |
| Recruiting | Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease Mycobacterium Avium Complex, Mycobacterium Avium-Intracellulare Infection, Gram-Positive Bacterial Infections | — | 2023-04-14 |
| Completed | CX3CR1+T Cell Predict Immunotherapy Efficacy Non-small Cell Lung Cancer | — | 2023-04-10 |
| Recruiting | Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced No Locally Advanced, Non-small Cell Lung Cancer | Phase 2 | 2023-03-14 |
| Completed | Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection Thoracic Diseases, Thoracic Surgery | — | 2023-01-29 |
| Unknown | Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma Lung Adenocarcinoma, Radiomics, Grading System | — | 2022-11-01 |
| Recruiting | Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer Non-small Cell Lung Cancer Stage III | Phase 2 | 2022-09-10 |
| Recruiting | Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis Cystic Fibrosis, Pulmonary | — | 2022-09-07 |
| Unknown | Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease Nontuberculous Mycobacterial Lung Disease | Phase 4 | 2022-08-05 |
| Recruiting | A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB MDR-TB, Immunotherapy | Phase 4 | 2022-08-03 |
| Unknown | Clinical Characteristics of Lung Cancer in China Lung Cancer | — | 2022-07-01 |
| Completed | Assessment of an Exhaled Breath Test to Detect Bronchiectasis Bronchiectasis | — | 2022-07-01 |
| Unknown | Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy Thymoma, Myasthenia Gravis Associated With Thymoma, Thymectomy | N/A | 2022-05-10 |
| Recruiting | Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resecta Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation | Phase 2 | 2022-02-01 |
| Unknown | Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer Non-small Cell Lung Cancer | — | 2022-01-01 |
| Active Not Recruiting | Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-smal Non-small Cell Lung Cancer Stage III | Phase 2 | 2021-12-14 |
| Unknown | Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy Small Cell Lung Cancer | Phase 2 | 2021-11-01 |
| Unknown | Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy Small Cell Lung Cancer | Phase 2 | 2021-07-25 |
| Unknown | Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults Acute Exacerbation of Bronchiectasis | Phase 4 | 2021-06-30 |
| Unknown | Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform Mycobacterium Pulmonary Infection | — | 2021-06-28 |
| Unknown | Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-C Small-cell Lung Cancer | Phase 2 | 2021-05-01 |
| Completed | A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB MDR-TB | Phase 4 | 2021-04-01 |
| Unknown | a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung C Extensive Stage Small Cell Lung Cancer | Phase 2 | 2021-04-01 |
| Not Yet Recruiting | Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008) Non Small Cell Lung Cancer | Phase 3 | 2021-03-31 |
| Recruiting | Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primar Multiple Primary Lung Cancer | Phase 2 | 2021-03-21 |
| Unknown | Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2021-02-08 |
| Unknown | Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma Tracheal Squamous Cell Carcinoma | Phase 2 | 2021-02-01 |
| Unknown | Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma | Phase 2 | 2021-02-01 |
| Unknown | Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithe Thymic Epithelial Tumor | Phase 2 | 2021-01-31 |
| Unknown | Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bro Advanced Lung Carcinoma, Non-small Cell Lung Cancer | Phase 2 / Phase 3 | 2021-01-20 |
| Unknown | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Smal Small-cell Lung Cancer, Neoadjuvant Therapy | Phase 2 | 2021-01-01 |
| Unknown | Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis Bronchiectasis Adult | Phase 4 | 2021-01-01 |
| Unknown | Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy Lung Neoplasms | N/A | 2020-11-25 |
| Unknown | Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC Lung Cancer, Immunotherapy | — | 2020-09-01 |
| Unknown | Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation Bronchiectasis Adult | Phase 4 | 2020-09-01 |
| Recruiting | PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer Small-cell Lung Cancer | Phase 2 | 2020-09-01 |
| Unknown | Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Cryptogenic Organizing Pneumonia, Idiopathic Interstitial Pneumonias | — | 2020-08-07 |
| Active Not Recruiting | Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2020-07-26 |
| Completed | Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma Lung Adenocarcinoma Stage III, EGFR Gene Mutation | Phase 2 | 2020-07-26 |
| Terminated | Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2020-07-13 |
| Completed | Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial Lung Neoplasms | N/A | 2020-06-01 |
| Unknown | Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors Non Small Cell Lung Cancer, Influenza Vaccine | — | 2020-06-01 |
| Unknown | Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC Effect Increased, Safety Issues | N/A | 2020-05-01 |
| Unknown | Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Advanced NSCLC, Circulating Tumor Cells, Circulating Tumor DNA | — | 2020-01-15 |
| Completed | A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer SMARCA4-Deficient Tumor, NSCLC (Advanced Non-small Cell Lung Cancer) | — | 2020-01-01 |
| Completed | Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis Pulmonary Alveolar Proteinosis | — | 2020-01-01 |
| Unknown | Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients Lung Cancer | — | 2019-11-10 |
| Unknown | Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer Healthy, Pulmonary Nodule | — | 2019-11-01 |
| Unknown | Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene M Chinese, Non-Small Cell Lung Cancer | — | 2019-10-25 |
| Recruiting | Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm Lung Adenocarcinoma | N/A | 2019-10-01 |
| Recruiting | Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm Lung Adenocarcinoma | — | 2019-08-20 |
| Unknown | Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population. Bronchiectasis | — | 2019-08-01 |
| Unknown | VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer Lung Cancer, Surgery | Phase 3 | 2019-06-01 |
| Unknown | Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary No Cryptococcosis, Lung Adenocarcinoma | — | 2019-01-01 |
| Unknown | The Establishment of China Bronchiectasis Registry and Research Collaboration Bronchiectasis | — | 2019-01-01 |
| Unknown | NGS Combined With RNAseq on Tumor Immune Escape in NSCLC Non-small Cell Lung Cancer | — | 2018-12-01 |
| Completed | Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis Bronchiectasis | — | 2018-06-25 |
| Completed | Idiopathic Bronchiectasis and Pulmonary Hypertension Bronchiectasis, Pulmonary Hypertension | — | 2018-06-01 |
| Completed | Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation Bronchiectasis Adult | — | 2018-02-01 |
| Unknown | Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmon Lymph Node Excision | N/A | 2017-12-08 |
| Completed | Pilot Clinical Trial of PRS TB Regimen I - Phase II Pulmonary Tuberculosis TB in Sputum: (+) Microscopy | Phase 4 | 2017-12-01 |
| Completed | Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer Lung Neoplasms, Thoracic Surgery, Carcinoma, Non-Small-Cell Lung | Phase 3 | 2017-11-10 |
| Unknown | NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy Non - Tuberculosis Mycobacteria Lung Disease | N/A | 2017-10-09 |
| Unknown | Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis COPD, Bronchiectasis | Phase 4 | 2017-09-15 |
| Recruiting | Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% Chemotherapy, Adjuvant, Lung Adenocarcinoma, Stage I, Treatment | Phase 2 | 2017-09-01 |
| Unknown | EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism Nonsmall Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | 2016-12-01 |
| Unknown | EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism Non-Small-Cell Lung Cancer | Phase 3 | 2016-08-01 |
| Unknown | Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (A Interstitial Lung Diseases | — | 2015-08-01 |
| Completed | Corticosteroid Treatment for Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome | — | 2015-01-01 |
| Unknown | Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Bronchiectasis | Phase 4 | 2015-01-01 |
| Unknown | Cytokine Profile of Allergic Bronchopulmonary Aspergillosis ABPA | — | 2014-12-01 |
| Unknown | Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchie Bronchiectasis | Phase 4 | 2014-12-01 |
| Completed | The Role of KL-6 in the Clinical Diagnosis of ILD Interstitial Lung Disease | — | 2013-12-01 |
| Unknown | Research on New Regimens for Retreatment Pulmonary Tuberculosis Reinfection Pulmonary Tuberculosis | Phase 4 | 2013-06-01 |
| Unknown | Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. Pulmonary Alveolar Proteinosis | Phase 2 | 2012-01-01 |
| Completed | Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2011-12-01 |
| Completed | Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis Bronchiectasis | Phase 4 | 2011-06-01 |